0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Peripheral Intervention Drug-Eluting Devices Market Research Report 2024
Published Date: January 2024
|
Report Code: QYRE-Auto-19H2840
Home | Market Reports | Health| Medical Devices & Equipment
Global Peripheral Intervention Drug Eluting Devices Market Insights and Forecast to 2028
BUY CHAPTERS

Global Peripheral Intervention Drug-Eluting Devices Market Research Report 2024

Code: QYRE-Auto-19H2840
Report
January 2024
Pages:87
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Peripheral Intervention Drug-Eluting Devices Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Peripheral Intervention Drug-Eluting Devices Market

Peripheral Intervention Drug-Eluting Devices Market

Drug eluting devices are devices that are coated with anti-proliferated agent. These devices exert antirestenotic efficacy on the vessel wall to remove the blockade within the blood vessels caused by deposition of plaque.
The global Peripheral Intervention Drug-Eluting Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Peripheral Intervention Drug-Eluting Devices, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Peripheral Intervention Drug-Eluting Devices.

Report Scope

The Peripheral Intervention Drug-Eluting Devices market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Peripheral Intervention Drug-Eluting Devices market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Peripheral Intervention Drug-Eluting Devices manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Peripheral Intervention Drug-Eluting Devices Market Report

Report Metric Details
Report Name Peripheral Intervention Drug-Eluting Devices Market
CAGR 5%
Segment by Type
  • Drug-Eluting Balloons
  • Drug-Eluting Stents
Segment by Application
  • Plain Old Balloon Angioplasty (POBA)
  • Percutaneous Transluminal Angioplasty (PTA)
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Medtronic plc, Boston Scientific Corporation, Abbott Laboratories, Cardinal Health, B. Braun Melsungen AG, Biosensors International Group Ltd., C.R. Bard, Inc., Abbott, The Lubrizol Corporation, Terumo Corporation
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Peripheral Intervention Drug-Eluting Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Peripheral Intervention Drug-Eluting Devices in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Peripheral Intervention Drug-Eluting Devices Market report?

Ans: The main players in the Peripheral Intervention Drug-Eluting Devices Market are Medtronic plc, Boston Scientific Corporation, Abbott Laboratories, Cardinal Health, B. Braun Melsungen AG, Biosensors International Group Ltd., C.R. Bard, Inc., Abbott, The Lubrizol Corporation, Terumo Corporation

What are the Application segmentation covered in the Peripheral Intervention Drug-Eluting Devices Market report?

Ans: The Applications covered in the Peripheral Intervention Drug-Eluting Devices Market report are Plain Old Balloon Angioplasty (POBA), Percutaneous Transluminal Angioplasty (PTA)

What are the Type segmentation covered in the Peripheral Intervention Drug-Eluting Devices Market report?

Ans: The Types covered in the Peripheral Intervention Drug-Eluting Devices Market report are Drug-Eluting Balloons, Drug-Eluting Stents

1 Peripheral Intervention Drug-Eluting Devices Market Overview
1.1 Product Overview and Scope of Peripheral Intervention Drug-Eluting Devices
1.2 Peripheral Intervention Drug-Eluting Devices Segment by Type
1.2.1 Global Peripheral Intervention Drug-Eluting Devices Market Value Comparison by Type (2024-2030)
1.2.2 Drug-Eluting Balloons
1.2.3 Drug-Eluting Stents
1.3 Peripheral Intervention Drug-Eluting Devices Segment by Application
1.3.1 Global Peripheral Intervention Drug-Eluting Devices Market Value by Application: (2024-2030)
1.3.2 Plain Old Balloon Angioplasty (POBA)
1.3.3 Percutaneous Transluminal Angioplasty (PTA)
1.4 Global Peripheral Intervention Drug-Eluting Devices Market Size Estimates and Forecasts
1.4.1 Global Peripheral Intervention Drug-Eluting Devices Revenue 2019-2030
1.4.2 Global Peripheral Intervention Drug-Eluting Devices Sales 2019-2030
1.4.3 Global Peripheral Intervention Drug-Eluting Devices Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Peripheral Intervention Drug-Eluting Devices Market Competition by Manufacturers
2.1 Global Peripheral Intervention Drug-Eluting Devices Sales Market Share by Manufacturers (2019-2024)
2.2 Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Peripheral Intervention Drug-Eluting Devices Average Price by Manufacturers (2019-2024)
2.4 Global Peripheral Intervention Drug-Eluting Devices Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Peripheral Intervention Drug-Eluting Devices, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Peripheral Intervention Drug-Eluting Devices, Product Type & Application
2.7 Peripheral Intervention Drug-Eluting Devices Market Competitive Situation and Trends
2.7.1 Peripheral Intervention Drug-Eluting Devices Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Peripheral Intervention Drug-Eluting Devices Players Market Share by Revenue
2.7.3 Global Peripheral Intervention Drug-Eluting Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Peripheral Intervention Drug-Eluting Devices Retrospective Market Scenario by Region
3.1 Global Peripheral Intervention Drug-Eluting Devices Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Peripheral Intervention Drug-Eluting Devices Global Peripheral Intervention Drug-Eluting Devices Sales by Region: 2019-2030
3.2.1 Global Peripheral Intervention Drug-Eluting Devices Sales by Region: 2019-2024
3.2.2 Global Peripheral Intervention Drug-Eluting Devices Sales by Region: 2025-2030
3.3 Global Peripheral Intervention Drug-Eluting Devices Global Peripheral Intervention Drug-Eluting Devices Revenue by Region: 2019-2030
3.3.1 Global Peripheral Intervention Drug-Eluting Devices Revenue by Region: 2019-2024
3.3.2 Global Peripheral Intervention Drug-Eluting Devices Revenue by Region: 2025-2030
3.4 North America Peripheral Intervention Drug-Eluting Devices Market Facts & Figures by Country
3.4.1 North America Peripheral Intervention Drug-Eluting Devices Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Peripheral Intervention Drug-Eluting Devices Sales by Country (2019-2030)
3.4.3 North America Peripheral Intervention Drug-Eluting Devices Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Peripheral Intervention Drug-Eluting Devices Market Facts & Figures by Country
3.5.1 Europe Peripheral Intervention Drug-Eluting Devices Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Peripheral Intervention Drug-Eluting Devices Sales by Country (2019-2030)
3.5.3 Europe Peripheral Intervention Drug-Eluting Devices Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Peripheral Intervention Drug-Eluting Devices Market Facts & Figures by Country
3.6.1 Asia Pacific Peripheral Intervention Drug-Eluting Devices Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Peripheral Intervention Drug-Eluting Devices Sales by Country (2019-2030)
3.6.3 Asia Pacific Peripheral Intervention Drug-Eluting Devices Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Peripheral Intervention Drug-Eluting Devices Market Facts & Figures by Country
3.7.1 Latin America Peripheral Intervention Drug-Eluting Devices Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Peripheral Intervention Drug-Eluting Devices Sales by Country (2019-2030)
3.7.3 Latin America Peripheral Intervention Drug-Eluting Devices Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Peripheral Intervention Drug-Eluting Devices Market Facts & Figures by Country
3.8.1 Middle East and Africa Peripheral Intervention Drug-Eluting Devices Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Peripheral Intervention Drug-Eluting Devices Sales by Country (2019-2030)
3.8.3 Middle East and Africa Peripheral Intervention Drug-Eluting Devices Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Peripheral Intervention Drug-Eluting Devices Sales by Type (2019-2030)
4.1.1 Global Peripheral Intervention Drug-Eluting Devices Sales by Type (2019-2024)
4.1.2 Global Peripheral Intervention Drug-Eluting Devices Sales by Type (2025-2030)
4.1.3 Global Peripheral Intervention Drug-Eluting Devices Sales Market Share by Type (2019-2030)
4.2 Global Peripheral Intervention Drug-Eluting Devices Revenue by Type (2019-2030)
4.2.1 Global Peripheral Intervention Drug-Eluting Devices Revenue by Type (2019-2024)
4.2.2 Global Peripheral Intervention Drug-Eluting Devices Revenue by Type (2025-2030)
4.2.3 Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Type (2019-2030)
4.3 Global Peripheral Intervention Drug-Eluting Devices Price by Type (2019-2030)
5 Segment by Application
5.1 Global Peripheral Intervention Drug-Eluting Devices Sales by Application (2019-2030)
5.1.1 Global Peripheral Intervention Drug-Eluting Devices Sales by Application (2019-2024)
5.1.2 Global Peripheral Intervention Drug-Eluting Devices Sales by Application (2025-2030)
5.1.3 Global Peripheral Intervention Drug-Eluting Devices Sales Market Share by Application (2019-2030)
5.2 Global Peripheral Intervention Drug-Eluting Devices Revenue by Application (2019-2030)
5.2.1 Global Peripheral Intervention Drug-Eluting Devices Revenue by Application (2019-2024)
5.2.2 Global Peripheral Intervention Drug-Eluting Devices Revenue by Application (2025-2030)
5.2.3 Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Application (2019-2030)
5.3 Global Peripheral Intervention Drug-Eluting Devices Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Medtronic plc
6.1.1 Medtronic plc Corporation Information
6.1.2 Medtronic plc Description and Business Overview
6.1.3 Medtronic plc Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Medtronic plc Peripheral Intervention Drug-Eluting Devices Product Portfolio
6.1.5 Medtronic plc Recent Developments/Updates
6.2 Boston Scientific Corporation
6.2.1 Boston Scientific Corporation Corporation Information
6.2.2 Boston Scientific Corporation Description and Business Overview
6.2.3 Boston Scientific Corporation Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Boston Scientific Corporation Peripheral Intervention Drug-Eluting Devices Product Portfolio
6.2.5 Boston Scientific Corporation Recent Developments/Updates
6.3 Abbott Laboratories
6.3.1 Abbott Laboratories Corporation Information
6.3.2 Abbott Laboratories Description and Business Overview
6.3.3 Abbott Laboratories Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Abbott Laboratories Peripheral Intervention Drug-Eluting Devices Product Portfolio
6.3.5 Abbott Laboratories Recent Developments/Updates
6.4 Cardinal Health
6.4.1 Cardinal Health Corporation Information
6.4.2 Cardinal Health Description and Business Overview
6.4.3 Cardinal Health Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Cardinal Health Peripheral Intervention Drug-Eluting Devices Product Portfolio
6.4.5 Cardinal Health Recent Developments/Updates
6.5 B. Braun Melsungen AG
6.5.1 B. Braun Melsungen AG Corporation Information
6.5.2 B. Braun Melsungen AG Description and Business Overview
6.5.3 B. Braun Melsungen AG Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Gross Margin (2019-2024)
6.5.4 B. Braun Melsungen AG Peripheral Intervention Drug-Eluting Devices Product Portfolio
6.5.5 B. Braun Melsungen AG Recent Developments/Updates
6.6 Biosensors International Group Ltd.
6.6.1 Biosensors International Group Ltd. Corporation Information
6.6.2 Biosensors International Group Ltd. Description and Business Overview
6.6.3 Biosensors International Group Ltd. Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Biosensors International Group Ltd. Peripheral Intervention Drug-Eluting Devices Product Portfolio
6.6.5 Biosensors International Group Ltd. Recent Developments/Updates
6.7 C.R. Bard, Inc.
6.6.1 C.R. Bard, Inc. Corporation Information
6.6.2 C.R. Bard, Inc. Description and Business Overview
6.6.3 C.R. Bard, Inc. Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Gross Margin (2019-2024)
6.4.4 C.R. Bard, Inc. Peripheral Intervention Drug-Eluting Devices Product Portfolio
6.7.5 C.R. Bard, Inc. Recent Developments/Updates
6.8 Abbott
6.8.1 Abbott Corporation Information
6.8.2 Abbott Description and Business Overview
6.8.3 Abbott Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Abbott Peripheral Intervention Drug-Eluting Devices Product Portfolio
6.8.5 Abbott Recent Developments/Updates
6.9 The Lubrizol Corporation
6.9.1 The Lubrizol Corporation Corporation Information
6.9.2 The Lubrizol Corporation Description and Business Overview
6.9.3 The Lubrizol Corporation Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Gross Margin (2019-2024)
6.9.4 The Lubrizol Corporation Peripheral Intervention Drug-Eluting Devices Product Portfolio
6.9.5 The Lubrizol Corporation Recent Developments/Updates
6.10 Terumo Corporation
6.10.1 Terumo Corporation Corporation Information
6.10.2 Terumo Corporation Description and Business Overview
6.10.3 Terumo Corporation Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Terumo Corporation Peripheral Intervention Drug-Eluting Devices Product Portfolio
6.10.5 Terumo Corporation Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Peripheral Intervention Drug-Eluting Devices Industry Chain Analysis
7.2 Peripheral Intervention Drug-Eluting Devices Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Peripheral Intervention Drug-Eluting Devices Production Mode & Process
7.4 Peripheral Intervention Drug-Eluting Devices Sales and Marketing
7.4.1 Peripheral Intervention Drug-Eluting Devices Sales Channels
7.4.2 Peripheral Intervention Drug-Eluting Devices Distributors
7.5 Peripheral Intervention Drug-Eluting Devices Customers
8 Peripheral Intervention Drug-Eluting Devices Market Dynamics
8.1 Peripheral Intervention Drug-Eluting Devices Industry Trends
8.2 Peripheral Intervention Drug-Eluting Devices Market Drivers
8.3 Peripheral Intervention Drug-Eluting Devices Market Challenges
8.4 Peripheral Intervention Drug-Eluting Devices Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
    Table 1. Global Peripheral Intervention Drug-Eluting Devices Market Value Comparison by Type (2024-2030) & (US$ Million)
    Table 2. Global Peripheral Intervention Drug-Eluting Devices Market Value Comparison by Application (2024-2030) & (US$ Million)
    Table 3. Global Peripheral Intervention Drug-Eluting Devices Market Competitive Situation by Manufacturers in 2023
    Table 4. Global Peripheral Intervention Drug-Eluting Devices Sales (K Units) of Key Manufacturers (2019-2024)
    Table 5. Global Peripheral Intervention Drug-Eluting Devices Sales Market Share by Manufacturers (2019-2024)
    Table 6. Global Peripheral Intervention Drug-Eluting Devices Revenue (US$ Million) by Manufacturers (2019-2024)
    Table 7. Global Peripheral Intervention Drug-Eluting Devices Revenue Share by Manufacturers (2019-2024)
    Table 8. Global Market Peripheral Intervention Drug-Eluting Devices Average Price (USD/Unit) of Key Manufacturers (2019-2024)
    Table 9. Global Key Players of Peripheral Intervention Drug-Eluting Devices, Industry Ranking, 2022 VS 2023 VS 2024
    Table 10. Global Key Manufacturers of Peripheral Intervention Drug-Eluting Devices, Manufacturing Sites & Headquarters
    Table 11. Global Key Manufacturers of Peripheral Intervention Drug-Eluting Devices, Product Type & Application
    Table 12. Global Key Manufacturers of Peripheral Intervention Drug-Eluting Devices, Date of Enter into This Industry
    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Peripheral Intervention Drug-Eluting Devices by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peripheral Intervention Drug-Eluting Devices as of 2023)
    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 16. Global Peripheral Intervention Drug-Eluting Devices Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 17. Global Peripheral Intervention Drug-Eluting Devices Sales by Region (2019-2024) & (K Units)
    Table 18. Global Peripheral Intervention Drug-Eluting Devices Sales Market Share by Region (2019-2024)
    Table 19. Global Peripheral Intervention Drug-Eluting Devices Sales by Region (2025-2030) & (K Units)
    Table 20. Global Peripheral Intervention Drug-Eluting Devices Sales Market Share by Region (2025-2030)
    Table 21. Global Peripheral Intervention Drug-Eluting Devices Revenue by Region (2019-2024) & (US$ Million)
    Table 22. Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Region (2019-2024)
    Table 23. Global Peripheral Intervention Drug-Eluting Devices Revenue by Region (2025-2030) & (US$ Million)
    Table 24. Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Region (2025-2030)
    Table 25. North America Peripheral Intervention Drug-Eluting Devices Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 26. North America Peripheral Intervention Drug-Eluting Devices Sales by Country (2019-2024) & (K Units)
    Table 27. North America Peripheral Intervention Drug-Eluting Devices Sales by Country (2025-2030) & (K Units)
    Table 28. North America Peripheral Intervention Drug-Eluting Devices Revenue by Country (2019-2024) & (US$ Million)
    Table 29. North America Peripheral Intervention Drug-Eluting Devices Revenue by Country (2025-2030) & (US$ Million)
    Table 30. Europe Peripheral Intervention Drug-Eluting Devices Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 31. Europe Peripheral Intervention Drug-Eluting Devices Sales by Country (2019-2024) & (K Units)
    Table 32. Europe Peripheral Intervention Drug-Eluting Devices Sales by Country (2025-2030) & (K Units)
    Table 33. Europe Peripheral Intervention Drug-Eluting Devices Revenue by Country (2019-2024) & (US$ Million)
    Table 34. Europe Peripheral Intervention Drug-Eluting Devices Revenue by Country (2025-2030) & (US$ Million)
    Table 35. Asia Pacific Peripheral Intervention Drug-Eluting Devices Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 36. Asia Pacific Peripheral Intervention Drug-Eluting Devices Sales by Region (2019-2024) & (K Units)
    Table 37. Asia Pacific Peripheral Intervention Drug-Eluting Devices Sales by Region (2025-2030) & (K Units)
    Table 38. Asia Pacific Peripheral Intervention Drug-Eluting Devices Revenue by Region (2019-2024) & (US$ Million)
    Table 39. Asia Pacific Peripheral Intervention Drug-Eluting Devices Revenue by Region (2025-2030) & (US$ Million)
    Table 40. Latin America Peripheral Intervention Drug-Eluting Devices Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Latin America Peripheral Intervention Drug-Eluting Devices Sales by Country (2019-2024) & (K Units)
    Table 42. Latin America Peripheral Intervention Drug-Eluting Devices Sales by Country (2025-2030) & (K Units)
    Table 43. Latin America Peripheral Intervention Drug-Eluting Devices Revenue by Country (2019-2024) & (US$ Million)
    Table 44. Latin America Peripheral Intervention Drug-Eluting Devices Revenue by Country (2025-2030) & (US$ Million)
    Table 45. Middle East & Africa Peripheral Intervention Drug-Eluting Devices Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 46. Middle East & Africa Peripheral Intervention Drug-Eluting Devices Sales by Country (2019-2024) & (K Units)
    Table 47. Middle East & Africa Peripheral Intervention Drug-Eluting Devices Sales by Country (2025-2030) & (K Units)
    Table 48. Middle East & Africa Peripheral Intervention Drug-Eluting Devices Revenue by Country (2019-2024) & (US$ Million)
    Table 49. Middle East & Africa Peripheral Intervention Drug-Eluting Devices Revenue by Country (2025-2030) & (US$ Million)
    Table 50. Global Peripheral Intervention Drug-Eluting Devices Sales (K Units) by Type (2019-2024)
    Table 51. Global Peripheral Intervention Drug-Eluting Devices Sales (K Units) by Type (2025-2030)
    Table 52. Global Peripheral Intervention Drug-Eluting Devices Sales Market Share by Type (2019-2024)
    Table 53. Global Peripheral Intervention Drug-Eluting Devices Sales Market Share by Type (2025-2030)
    Table 54. Global Peripheral Intervention Drug-Eluting Devices Revenue (US$ Million) by Type (2019-2024)
    Table 55. Global Peripheral Intervention Drug-Eluting Devices Revenue (US$ Million) by Type (2025-2030)
    Table 56. Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Type (2019-2024)
    Table 57. Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Type (2025-2030)
    Table 58. Global Peripheral Intervention Drug-Eluting Devices Price (USD/Unit) by Type (2019-2024)
    Table 59. Global Peripheral Intervention Drug-Eluting Devices Price (USD/Unit) by Type (2025-2030)
    Table 60. Global Peripheral Intervention Drug-Eluting Devices Sales (K Units) by Application (2019-2024)
    Table 61. Global Peripheral Intervention Drug-Eluting Devices Sales (K Units) by Application (2025-2030)
    Table 62. Global Peripheral Intervention Drug-Eluting Devices Sales Market Share by Application (2019-2024)
    Table 63. Global Peripheral Intervention Drug-Eluting Devices Sales Market Share by Application (2025-2030)
    Table 64. Global Peripheral Intervention Drug-Eluting Devices Revenue (US$ Million) by Application (2019-2024)
    Table 65. Global Peripheral Intervention Drug-Eluting Devices Revenue (US$ Million) by Application (2025-2030)
    Table 66. Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Application (2019-2024)
    Table 67. Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Application (2025-2030)
    Table 68. Global Peripheral Intervention Drug-Eluting Devices Price (USD/Unit) by Application (2019-2024)
    Table 69. Global Peripheral Intervention Drug-Eluting Devices Price (USD/Unit) by Application (2025-2030)
    Table 70. Medtronic plc Corporation Information
    Table 71. Medtronic plc Description and Business Overview
    Table 72. Medtronic plc Peripheral Intervention Drug-Eluting Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 73. Medtronic plc Peripheral Intervention Drug-Eluting Devices Product
    Table 74. Medtronic plc Recent Developments/Updates
    Table 75. Boston Scientific Corporation Corporation Information
    Table 76. Boston Scientific Corporation Description and Business Overview
    Table 77. Boston Scientific Corporation Peripheral Intervention Drug-Eluting Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 78. Boston Scientific Corporation Peripheral Intervention Drug-Eluting Devices Product
    Table 79. Boston Scientific Corporation Recent Developments/Updates
    Table 80. Abbott Laboratories Corporation Information
    Table 81. Abbott Laboratories Description and Business Overview
    Table 82. Abbott Laboratories Peripheral Intervention Drug-Eluting Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 83. Abbott Laboratories Peripheral Intervention Drug-Eluting Devices Product
    Table 84. Abbott Laboratories Recent Developments/Updates
    Table 85. Cardinal Health Corporation Information
    Table 86. Cardinal Health Description and Business Overview
    Table 87. Cardinal Health Peripheral Intervention Drug-Eluting Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 88. Cardinal Health Peripheral Intervention Drug-Eluting Devices Product
    Table 89. Cardinal Health Recent Developments/Updates
    Table 90. B. Braun Melsungen AG Corporation Information
    Table 91. B. Braun Melsungen AG Description and Business Overview
    Table 92. B. Braun Melsungen AG Peripheral Intervention Drug-Eluting Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 93. B. Braun Melsungen AG Peripheral Intervention Drug-Eluting Devices Product
    Table 94. B. Braun Melsungen AG Recent Developments/Updates
    Table 95. Biosensors International Group Ltd. Corporation Information
    Table 96. Biosensors International Group Ltd. Description and Business Overview
    Table 97. Biosensors International Group Ltd. Peripheral Intervention Drug-Eluting Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 98. Biosensors International Group Ltd. Peripheral Intervention Drug-Eluting Devices Product
    Table 99. Biosensors International Group Ltd. Recent Developments/Updates
    Table 100. C.R. Bard, Inc. Corporation Information
    Table 101. C.R. Bard, Inc. Description and Business Overview
    Table 102. C.R. Bard, Inc. Peripheral Intervention Drug-Eluting Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 103. C.R. Bard, Inc. Peripheral Intervention Drug-Eluting Devices Product
    Table 104. C.R. Bard, Inc. Recent Developments/Updates
    Table 105. Abbott Corporation Information
    Table 106. Abbott Description and Business Overview
    Table 107. Abbott Peripheral Intervention Drug-Eluting Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 108. Abbott Peripheral Intervention Drug-Eluting Devices Product
    Table 109. Abbott Recent Developments/Updates
    Table 110. The Lubrizol Corporation Corporation Information
    Table 111. The Lubrizol Corporation Description and Business Overview
    Table 112. The Lubrizol Corporation Peripheral Intervention Drug-Eluting Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 113. The Lubrizol Corporation Peripheral Intervention Drug-Eluting Devices Product
    Table 114. The Lubrizol Corporation Recent Developments/Updates
    Table 115. Terumo Corporation Corporation Information
    Table 116. Terumo Corporation Description and Business Overview
    Table 117. Terumo Corporation Peripheral Intervention Drug-Eluting Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 118. Terumo Corporation Peripheral Intervention Drug-Eluting Devices Product
    Table 119. Terumo Corporation Recent Developments/Updates
    Table 120. Key Raw Materials Lists
    Table 121. Raw Materials Key Suppliers Lists
    Table 122. Peripheral Intervention Drug-Eluting Devices Distributors List
    Table 123. Peripheral Intervention Drug-Eluting Devices Customers List
    Table 124. Peripheral Intervention Drug-Eluting Devices Market Trends
    Table 125. Peripheral Intervention Drug-Eluting Devices Market Drivers
    Table 126. Peripheral Intervention Drug-Eluting Devices Market Challenges
    Table 127. Peripheral Intervention Drug-Eluting Devices Market Restraints
    Table 128. Research Programs/Design for This Report
    Table 129. Key Data Information from Secondary Sources
    Table 130. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Peripheral Intervention Drug-Eluting Devices
    Figure 2. Global Peripheral Intervention Drug-Eluting Devices Market Value Comparison by Type (2024-2030) & (US$ Million)
    Figure 3. Global Peripheral Intervention Drug-Eluting Devices Market Share by Type in 2023 & 2030
    Figure 4. Drug-Eluting Balloons Product Picture
    Figure 5. Drug-Eluting Stents Product Picture
    Figure 6. Global Peripheral Intervention Drug-Eluting Devices Market Value Comparison by Application (2024-2030) & (US$ Million)
    Figure 7. Global Peripheral Intervention Drug-Eluting Devices Market Share by Application in 2023 & 2030
    Figure 8. Plain Old Balloon Angioplasty (POBA)
    Figure 9. Percutaneous Transluminal Angioplasty (PTA)
    Figure 10. Global Peripheral Intervention Drug-Eluting Devices Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 11. Global Peripheral Intervention Drug-Eluting Devices Market Size (2019-2030) & (US$ Million)
    Figure 12. Global Peripheral Intervention Drug-Eluting Devices Sales (2019-2030) & (K Units)
    Figure 13. Global Peripheral Intervention Drug-Eluting Devices Average Price (USD/Unit) & (2019-2030)
    Figure 14. Peripheral Intervention Drug-Eluting Devices Report Years Considered
    Figure 15. Peripheral Intervention Drug-Eluting Devices Sales Share by Manufacturers in 2023
    Figure 16. Global Peripheral Intervention Drug-Eluting Devices Revenue Share by Manufacturers in 2023
    Figure 17. The Global 5 and 10 Largest Peripheral Intervention Drug-Eluting Devices Players: Market Share by Revenue in 2023
    Figure 18. Peripheral Intervention Drug-Eluting Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
    Figure 19. Global Peripheral Intervention Drug-Eluting Devices Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Figure 20. North America Peripheral Intervention Drug-Eluting Devices Sales Market Share by Country (2019-2030)
    Figure 21. North America Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Country (2019-2030)
    Figure 22. U.S. Peripheral Intervention Drug-Eluting Devices Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 23. Canada Peripheral Intervention Drug-Eluting Devices Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 24. Europe Peripheral Intervention Drug-Eluting Devices Sales Market Share by Country (2019-2030)
    Figure 25. Europe Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Country (2019-2030)
    Figure 26. Germany Peripheral Intervention Drug-Eluting Devices Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 27. France Peripheral Intervention Drug-Eluting Devices Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 28. U.K. Peripheral Intervention Drug-Eluting Devices Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 29. Italy Peripheral Intervention Drug-Eluting Devices Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 30. Russia Peripheral Intervention Drug-Eluting Devices Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 31. Asia Pacific Peripheral Intervention Drug-Eluting Devices Sales Market Share by Region (2019-2030)
    Figure 32. Asia Pacific Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Region (2019-2030)
    Figure 33. China Peripheral Intervention Drug-Eluting Devices Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 34. Japan Peripheral Intervention Drug-Eluting Devices Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 35. South Korea Peripheral Intervention Drug-Eluting Devices Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 36. India Peripheral Intervention Drug-Eluting Devices Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 37. Australia Peripheral Intervention Drug-Eluting Devices Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 38. Taiwan Peripheral Intervention Drug-Eluting Devices Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 39. Indonesia Peripheral Intervention Drug-Eluting Devices Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 40. Thailand Peripheral Intervention Drug-Eluting Devices Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 41. Malaysia Peripheral Intervention Drug-Eluting Devices Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 42. Philippines Peripheral Intervention Drug-Eluting Devices Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 43. Latin America Peripheral Intervention Drug-Eluting Devices Sales Market Share by Country (2019-2030)
    Figure 44. Latin America Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Country (2019-2030)
    Figure 45. Mexico Peripheral Intervention Drug-Eluting Devices Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 46. Brazil Peripheral Intervention Drug-Eluting Devices Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 47. Argentina Peripheral Intervention Drug-Eluting Devices Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 48. Middle East & Africa Peripheral Intervention Drug-Eluting Devices Sales Market Share by Country (2019-2030)
    Figure 49. Middle East & Africa Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Country (2019-2030)
    Figure 50. Turkey Peripheral Intervention Drug-Eluting Devices Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 51. Saudi Arabia Peripheral Intervention Drug-Eluting Devices Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 52. U.A.E Peripheral Intervention Drug-Eluting Devices Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 53. Global Sales Market Share of Peripheral Intervention Drug-Eluting Devices by Type (2019-2030)
    Figure 54. Global Revenue Market Share of Peripheral Intervention Drug-Eluting Devices by Type (2019-2030)
    Figure 55. Global Peripheral Intervention Drug-Eluting Devices Price (USD/Unit) by Type (2019-2030)
    Figure 56. Global Sales Market Share of Peripheral Intervention Drug-Eluting Devices by Application (2019-2030)
    Figure 57. Global Revenue Market Share of Peripheral Intervention Drug-Eluting Devices by Application (2019-2030)
    Figure 58. Global Peripheral Intervention Drug-Eluting Devices Price (USD/Unit) by Application (2019-2030)
    Figure 59. Peripheral Intervention Drug-Eluting Devices Value Chain
    Figure 60. Peripheral Intervention Drug-Eluting Devices Production Process
    Figure 61. Channels of Distribution (Direct Vs Distribution)
    Figure 62. Distributors Profiles
    Figure 63. Bottom-up and Top-down Approaches for This Report
    Figure 64. Data Triangulation
    Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Accenture

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Shortwave Therapy Apparatus - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-11C13925
Thu Nov 07 00:00:00 UTC 2024

Add to Cart

Postural Therapy Beds - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-4V14062
Thu Nov 07 00:00:00 UTC 2024

Add to Cart

Medical Liquid Crystal Display - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-38E13307
Thu Nov 07 00:00:00 UTC 2024

Add to Cart

Ultrashort Wave Therapeutic Apparatus - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-7B14006
Thu Nov 07 00:00:00 UTC 2024

Add to Cart